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Summary
Bartter syndrome (BS) is a family of disordersmanifested
by hypokalemic hypochloremic metabolic alkalosis with
normotensive hyperreninemic hyperaldosteronism. We
evaluated a unique, inbred Bedouin kindred in which
sensorineural deafness (SND) cosegregates with an in-
fantile variant of the BS phenotype. Using a DNA-pool-
ing strategy, we screened the human genome and suc-
cessfully demonstrated linkage of this unique syndrome
to chromosome 1p31. The genes for two kidney-specific
chloride channels and a sodium/hydrogen antiporter, lo-
cated near this region, were excluded as candidate genes.
Although the search for the disease-causing gene in this
family continues, this linkage further demonstrates the
genetic heterogeneity of BS. In addition, the cosegre-
gation of these phenotypes allows us to postulate that
a single genetic alteration may be responsible for the
SND and the BS phenotype. The identification and char-
acterization of this gene would lead to a better under-
standing of the normal physiology of the kidney and the
inner ear.
Introduction
Bartter syndrome (BS; OMIM 241200 [http://
www3.ncbi.nlm.nih.gov:80/htbin-post/Omim.dispmim
?241200]) is an autosomal recessive disorder defined
by hypokalemic metabolic alkalosis (Bartter et al.
1962; Rodrigues and van Wersch 1983; Clive 1995).
Affected individuals also have elevated plasma renin
activity and hyperaldosteronism, with normal blood
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pressure, altered prostaglandin metabolism (with in-
creased levels of urinary prostaglandins), and increased
urinary chloride excretion. Since the original report on
BS, by Bartter et al. (1962), there has been much debate
regarding the primary defect resulting in this syndrome
(Clive 1995). To date, the consensus is that there are
two major genetic entities of tubular hypokalemic met-
abolic alkalosis (Seyberth et al. 1996): BS with earlier
clinical manifestations—including the infantile variant
of BS (IBS), or hyperprostaglandin E syndrome (OMIM
241200 [http://www3.ncbi.nlm.nih.gov:80/htbin-post/
Omim.dispmim?241200]), with severe perinatal man-
ifestations—and the more common Gitelman syndrome
(OMIM 263800 [http://www3.ncbi.nlm.nih.gov:80/
htbin-post/Omim.dispmim?263800]), with later onset
of symptoms and a relatively benign clinical course. In
addition to the age at onset and the clinical severity,
these disorders differ mainly in the occurrence of hy-
percalciuria and normal serum magnesium levels (in
BS) versus the occurrence of hypocalciuria and hypom-
agnesemia (in Gitelman syndrome).
Several studies to identify the genetic basis of BS have
been performed by use of a candidate-gene approach.
The genes for atrial natriuretic factor (Graham et al.
1986), angiotensin II type I receptor (Yoshida et al.
1994), and renin (Higaki and Ogihara 1992) have been
screened, and no polymorphism has been found to seg-
regate with the phenotype. However, Gitelman syn-
drome recently has been found to be caused by muta-
tions in the thiazide-sensitive Na-Cl cotransporter
(TSC) gene on chromosome 16 (Simon et al. 1996c).
Even more recently, mutations in the Na-K-2Cl co-
transporter gene on chromosome 15 have been identified
in affected members of five families with IBS (Simon et
al. 1996a). Functional studies have confirmed the ap-
parent loss of function of theNa-K-2Cl cotransporter
in patients with classic BS. These patients showed in-
sensitivity to furosemide infusion, compared with their
unaffected siblings and with patients with Gitelman syn-
drome (Kockerling et al. 1996). In addition, mutations
in the inwardly rectifying K-channel gene (ROMK) on
chromosome 11 have been identified in BS patients
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Figure 1 IBS with SND pedigree. Genotyping data are shown below the symbol for each individual. Males are represented by squares,
and females are represented by circles. Blackened symbols indicate individuals with IBS and SND, and unblackened symbols indicate unaffected
individuals. Boxed haplotypes denote affected chromosomes. Individuals used in the DNA-pooling strategy are marked with an asterisk (*).
Individual VI-2 was spontaneously aborted; sex was not determined. Individual VI-9 died of this disorder. Double slashes indicate lines of
inheritance that were broken, to simplify the pedigree for statistical analysis.
(Simon et al. 1996b). Finally, mutations in the chloride-
channel gene (CLCNKB) on chromosome 1 have been
identified in BS patients (Simon et al. 1997). The proteins
ROMK and CLCNKB are believed to regulate the Na-
K-2Cl cotransporter, and, thus, loss of function of
these proteins would produce a similar phenotype.
IBS has been reported in a previous study (Seyberth
et al. 1985). Affected patients are born prematurely and
present with prenatal maternal polyhydramnios and
postnatal polyuria, potassium depletion, volume con-
traction, and failure to thrive. Some of the infants were
reported to have severe hypercalciuria. Infants with IBS
also may have a prominent forehead, triangular facies
with drooping mouth, and large eyes and pinnae (Sey-
berth et al. 1985; Landau et al. 1995).
We have identified and evaluated an inbred Bedouin
kindred (fig. 1) with IBS with sensorineural deafness
(SND) (Landau et al. 1995). The Bedouin kindred in this
study is the first reported with the IBS variant with SND
(Landau et al. 1995). We report the use of a DNA-
pooling strategy to screen the human genome rapidly
and efficiently, to identify the locus causing this unique
variant of BS. We have mapped the disease-causing locus
to chromosome 1p31 and have excluded three candidate
genes on chromosome 1p. The identification of this locus
further demonstrates the genetic heterogeneity of BS.
Material and Methods
DNA Isolation and Genotyping
DNA was isolated and purified from peripheral blood
by use of standard protocols (Miller et al. 1988). DNA
concentrations were determined by spectrophotometric
readings at OD260 (optical density). On the basis of initial
spectrophotometric readings, samples were diluted to
100 ng/ml, and a second OD260 reading was taken to
confirm the concentration. The diluted samples then
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were PCR amplified to test the quality of the DNA and
to assure equal amplification. Equal amounts of diluted
DNA samples were pooled and diluted to a final con-
centration of 20 ng/ml. The affected pool comprised
DNA from five individuals with IBS with SND (fig. 1).
An unaffected-sibling pool comprised DNA from six in-
dividuals. The DNA from six parents of the affected
individuals also was pooled.
Cooperative Human Linkage Center short-tandem-re-
peat polymorphism (STRP) screening set version 6 (Re-
search Genetics) was used to screen the pooled DNA.
Amplification of STRP markers was performed by use
of 40 ng of pooled DNA in an 8.4-ml reaction mixture
containing 1.25 ml of 10# PCR buffer (100 mM Tris
HCL, pH 8.8, 15 mM MgCl2, and 0.01% w/v gelatin);
300 mM each of dATP, dCTP, dGTP, and dTTP; 2.5
pmol each of forward and reverse primers; and 0.25 U
of Taq DNA polymerase. Samples were subjected to 35
cycles of 94C for 30 s, 55C for 30 s, and 72C for 30
s. PCR products were analyzed on 6% denaturing poly-
acrylamide gels (7.7 M urea). Gels were silver stained
by use of the protocol used by Bassam et al. (1991).
Genotyping of individual family members was per-
formed as described above, by use of 40 ng of individual
DNA as template. Gels were scored independently by
two investigators.
Evaluation of Candidate Genes
In order to evaluate the candidate genes, primers were
selected from published sequences (Sardet et al. 1989;
Takeuchi et al. 1995) and were synthesized by use of
standard phosphoramidite chemistry. DNA was ampli-
fied by use of the PCR protocol described above. The
PCR fragments were evaluated by SSCP analysis as de-
scribed elsewhere (Sheffield et al. 1993). The primer se-
quences for the polymorphic fragment of the gene for
the kidney-specific chloride channel hClC-Kb are as fol-
lows: forward, 5′-GGC AAC ACC CTC TTC CTC-3′,
and reverse, 5′-CCT CAG ATG GCT TTT GTC AC-3′.
This primer pair amplifies a 207-bp product with a two-
allele polymorphism. The primer sequences for the ami-
loride-sensitive Na-H antiporter are as follows: for-
ward, 5′-CCC AGG ATT GTG CAA TAG TC-3′, and
reverse, 5′-TCT GTA CAG GCA GCA GAG TG-3′.
Radiation hybrid mapping was performed with the
GeneBridge 4 Radiation Hybrid Panel (Research Ge-
netics), by use of the PCR protocol described above. PCR
products were electrophoresed on 1.5% agarose gels and
were visualized with ethidium bromide. Products were
scored as positive according to correct size and equal
intensity, compared with that of the positive control;
lanes with a product of correct size but of lesser intensity
were scored as ambiguous. The reactions were per-
formed in duplicate and were submitted separately to
the Whitehead Institute/MIT Center for Genome Re-
search web site (http://www.genome.wi.mit.edu/).
Statistical Analysis of Linkage Data
LOD-score analysis was performed by use of the
MENDEL program. Given the complexity of the pedi-
gree, which has extensive consanguinity, the MENDEL
program could not be run on the original pedigree. The
pedigree was simplified by the breaking of inbreeding
loops in generations II–IV. These broken inbreeding
loops are indicated in figure 1 by a double slash through
the line of inheritance. The LOD scores determined by
use of the simplified pedigree were thought to be con-
servative, because of the loss of information resulting
from the breaking of these inbreeding loops.
Results
Phenotypic Data
We have identified an extended consanguineous Bed-
ouin kindred with IBS with SND (Landau et al. 1995).
The pedigree is shown in figure 1. The biochemical and
clinical data for this kindred have been described else-
where in detail (Landau et al. 1995). In brief, polyhy-
dramnios and subsequent premature birth had occurred
for all cases. Soon after birth, all patients developed
severe polyuria, resulting in salt wasting and a loss of
X25% of birth weight, with subsequent transient azo-
temia and hyponatremia. Hypokalemic metabolic al-
kalosis developed. Serum aldosterone and plasma renin
activities were elevated. Urinary excretion of prosta-
glandin E2 was markedly elevated. None of the patients
had hypomagnesemia, but all of them had hypercalci-
uria. In some cases, medullary nephrocalcinosis was
noted, by renal sonography. Hearing tests, performed as
part of the investigation of developmental delay or be-
cause of the family history, disclosed complete SND,
with the diagnosis made in one case at 3 wk of age, by
brain-stem auditory-evoked response, or BAER, exam-
ination. None of the described patients was treated with
an aminoglycoside or furosemide. None of the unaf-
fected family members showed any facial resemblance
to the patients, and no individuals with only either IBS
or deafness were found.
Linkage Data
In order to rapidly and efficiently identify the locus
causing IBS with SND, we utilized a DNA-pooling strat-
egy (Sheffield et al. 1994; Carmi et al. 1995). This ap-
proach assumes that affected individuals share a chro-
mosomal region inherited from a common ancestral
founder. Rapid screening for the IBS with SND locus
was accomplished by use of the affected and control
pooled DNA as template for 161 STRP markers. Link-
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Table 1
Two-Point Linkage Data between the Locus for IBS with SND
and Chromosome 1 Markers
MARKER
LOD SCORE AT v 
vmax Zmax.00 .05 .10 .20 .40
D1S1661  3.53 3.37 2.49 .67 .06 3.54
D1S417  3.06 2.91 2.10 .47 .05 3.06
D1S475 4.62 3.99 3.37 2.21 .46 .00 4.62
D1S200 7.51 6.57 5.63 3.83 .86 .00 7.51
D1S2690  3.22 3.06 2.21 .49 .05 3.22
Figure 2 Schematic diagram of chromosome 1p, indicating
linked region for IBS with SND. Distance between markers is shown
in centimorgans and is based on published maps (see the Center for
Medical Genetics web site [http://www.mfldclin.edu/genetics/]; Dib et
al. 1996). Cytogenetic location was obtained from the Human Tran-
script Map web site (http://www.ncbi.nlm.nih.gov/SCIENCE96/).
age was suggested by a significant reduction in the num-
ber of alleles with a single prominent allele in the affected
pool, compared with that in the controls (Sheffield et al.
1994; Carmi et al. 1995). Ten STRP markers, on seven
chromosomes, were viewed as candidate loci, on the
basis of the above criteria. These loci were evaluated
further by the screening of adjacent markers, again by
use of the pooling strategy. A locus was excluded if ad-
jacent markers did not display a pattern consistent with
linkage (i.e., there was no single prominent allele in the
affected DNA pool). Marker D1S2134, on chromosome
1, was a candidate locus, after the initial screening was
performed. In the subsequent screening, adjacent mark-
ers D1S2130 and D1S1669 displayed patterns consistent
with linkage. All other candidate loci from the first
screening were excluded in the second screening. The
chromosome 1 candidate region was evaluated further
by the genotyping of all available individuals in the ped-
igree, by use of marker D1S2134 and its adjacent mark-
ers. D1S2134 and its adjacent STRPs gave significantly
positive LOD scores. Marker D1S200, located ∼2.6 cM
centromeric to D1S2134, was found to be completely
informative and completely linked (see the Center for
Medical Genetics web site [http://www.mfldclin.edu/ge-
netics/]). The maximum LOD score (Zmax) for this
marker was 7.5 (recombination fraction of ). Thev  .00
genotyping data for this marker and its adjacentmarkers
are shown in figure 1. The IBS with SND locus lies within
a 3.4-cM region flanked by D1S1661 and D1S2690.
Additional fine mapping of this region is currently lim-
ited by the paucity of informative polymorphic markers
in this region. Table 1 summarizes the two-point max-
imum likelihood data between the linked markers in this
region and the disease phenotype. Cytogenetically, the
disease locus maps to 1p31, as shown in figure 2 (see
the Human Transcript Map web site [http://
www.ncbi.nlm.nih.gov/SCIENCE96/]).
Evaluation of Candidate Genes
Recently, the gene for two kidney-specific chloride
channels, hClC-Ka and hClC-Kb, have been identified
and characterized (Kieferle et al. 1994; Takeuchi et al.
1995). The hClC-Ka and hClC-Kb genes have been lo-
calized on chromosome 1p36, by FISH (Brandt and
Jentsch 1995). Primers were synthesized for the hClC-
Ka and hClC-Kb genes, and a two-allele polymorphism
in hClC-Kb was identified by SSCP analysis. For this
kindred, genotyping of individuals with this polymor-
phic marker excluded this gene, with a LOD score of
2 ( ). We were unable to identify a polymor-v  .23
phism in hClC-Ka; the coding sequences of these genes
were 190% homologous (Kieferle et al. 1994; Takeuchi
et al. 1995). However, the hClC-Ka gene has been
shown, by radiation hybrid mapping, to map near the
hClC-Kb gene and outside the disease interval (B. C.
Schutte and F. Lamb, unpublished data), thus excluding
this gene as a candidate.
Another candidate gene known to be near this cyto-
genetic region is the amiloride-sensitive Na-H anti-
porter (Mattei et al. 1988). Using primers that amplify
a fragment in the 3′ UTR (Sardet et al. 1989), we used
radiation hybrid mapping (Cox et al. 1990) to exclude
this gene, by defining its map location to be outside the
disease-causing region. Using the GeneBridge 4 Radia-
tion Hybrid Panel (Research Genetics), we linked this
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gene to WI-9232 and mapped it to the interval between
WI-9232 and WI-611 (LOD score 13.00), which is 160
cR telomeric to D1S417.
Discussion
Using a DNA-pooling strategy, we screened the human
genome and identified a locus causing IBS with SND in
this inbred Bedouin kindred. Linkage to this locus is
supported by a significantly positive LOD score of 7.5
and by homozygosity in all affected individuals. The
disease interval lies within a 3.4-cM region flanked by
D1S1661 and D1S2690 (fig. 1). Each flank is defined by
a recombination event in both an affected individual and
an unaffected individual.
BS has long been thought to be a heterogeneous group
of disorders. Stein (1985) divided BS patients into three
physiological subtypes: (1) patients with a primary po-
tassium-transport defect; (2) patients with primary Na-
Cl–transport defects in multiple nephron segments; and
(3) patients with a localized defect in Na-Cl transport
in the thick ascending limb of the loop of Henle (TALH).
The identification of mutations in the ROMK gene in
patients with classic BS (Simon et al. 1996b), the Na 
-Cl TSC in patients with Gitelman syndrome, and the
Na-K-2Cl cotransporter (Simon et al. 1996a) and the
chloride channel CLCNKB in patients with classic BS
demonstrates subsets 1, 2, and 3, respectively. The IBS
patients from the kindred investigated in this study have
biochemical abnormalities similar to those found in the
classic BS patients described by Simon et al. (1996a,
1996b, 1997). We have genetically excluded the Na-
K-2Cl cotransporter and CLCNKB (hClC-Kb) in our
kindred. By radiation hybrid mapping of the gene for
hClC-Ka, which is known to be located on chromosome
1p, we also have excluded it as the disease-causing gene
in this kindred. Another candidate gene is that for the
amiloride-sensitive Na-H antiporter, a ubiquitous
membrane-bound enzyme involved in pH regulation, via
the mediation of the exchange of intracellular H and
extracellular Na ions. This enzyme plays a major role
in the maintenance of intracellular pH and volume (Seif-
ter and Aronson 1986). The gene has been shown to
map to chromosome lp (Mattei et al. 1988). We have
confirmed the mapping of this gene to outside the disease
interval, by using radiation hybrid mapping.
The unique cosegregation of SND with this variant of
BS is quite intriguing. At least three mechanisms for the
cosegregation of these two phenotypes could be postu-
lated. First, given that all affected individuals have both
disorders (no individual in this kindred has isolated IBS
or SND), it would seem likely that a single pleotropic
gene is responsible for both the biochemical abnormal-
ities and the SND. Given that these patients are meta-
bolically indistinguishable from patients who abuse loop
diuretics and that it has been well documented that fu-
rosemide administration can result in hearing loss (Var-
gish et al. 1970; Lloyd-MostYn and Lord 1971), a com-
mon pathway responsible for these two phenotypes
could be postulated. The renal tubular cells of the TALH
actively maintain Na, K, and Cl homeostasis,
through the actions of the Na-K-2Cl cotransporter
in the tubular membrane and the Na-K ATPase in the
basolateral membrane of the renal tubular cells. The
administration of furosemide inhibits the Na-K-2Cl
cotransporter, resulting in loss of Na, K, and Cl in
the urine. This leads to volume depletion resulting in
activation of the renin-angiotensin system and hypo-
kalemia. The mechanism for furosemide-induced oto-
toxicity is not understood clearly, but furosemide may
act on the stria vascularis. The stria vascularis is im-
portant in generating the normally high resting endo-
cochlear potential necessary for normal hearing (Steel
and Brown 1994), and animal studies have shown re-
duced endocochlear potential after furosemide dosing
(Chodynicki and Kostrzewska 1974). It has been pro-
posed that the Na-K-2Cl cotransporter exists in the
marginal cells of the stria vascularis and that, in con-
junction with an Na-K ATPase, it maintains the K
and Cl ion gradients in these cells (Ikeda andMorizono
1989). Therefore, if furosemide can alter ion regulation
in the kidney and in the inner ear, leading to hypokalemic
metabolic alkalosis and sensorineural hearing loss, re-
spectively, a genetic defect in a gene encoding a single
protein regulating ion transport both within the renal
tubular cells of the TALH and within the marginal cells
of the stria vascularis could lead to both of these phe-
notypic abnormalities. This protein might directly reg-
ulate the Na-K-2Cl cotransporter, the ion current
within the renal tubular cells of the thick ascending limb
of the loop of Henle (ROMK, hClC-Kb, etc.), or the
second messenger signaling within these cells. The iden-
tification of the gene responsible for the BS phenotype
in this kindred will lead to a new understanding of the
physiology of salt and water regulation by the kidney,
as well as of the function of the inner ear in normal
hearing.
Second, we have not excluded the possibility that two
tightly linked genes are responsible for the cosegregation
of these phenotypes. Further refinement of the interval
and/or identification of the causative mutation(s) will aid
in the determination of the etiology of this cosegregation.
Finally, we cannot exclude completely the possibility that
the SND is secondary to the metabolic abnormalities of
IBS. However, this would appear to be unlikely, since
patients with hypokalemic metabolic alkalosis (second-
ary to a variant of BS, surreptitious vomiting, or diuretic
abuse) do not acquire SND. In IBS, the severity and early
onset of these metabolic abnormalities may increase the
risk of secondary physiologic alterations, but SND has
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not been seen in patients with similar manifestations
(Seyberth et al. 1985; Simon et al. 1996a, 1996b, 1997).
Moreover, testing of brain-stem auditory-evoked re-
sponses, performed on two affected individuals from this
family soon after birth, unequivocally showed severe
hearing loss. Ultimately, the mechanism will be eluci-
dated by the identification of the causative mutation(s)
in the disease gene(s).
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